A common diabetes drug could prevent dementia, with longer treatment being related to more benefits, a study in Korea has suggested. In over two lakh adults aged 40-69 years with type 2 diabetes, researchers found a 35 per cent reduced risk of dementia associated with taking a class of drugs known as sodium glucose cotransporter 2 inhibitors or SGLT-2 inhibitors, …
Heart failure patients are dying or becoming seriously ill because of severe delays in NHS treatment, experts have warned. A new study shows most patients who see their GP with heart failure symptoms, such as breathlessness, extreme fatigue and swollen ankles, wait at least a year to get a diagnosis from a cardiologist. ‘We regularly see patients dying while on …
Kidney stones are becoming increasingly common around the world. Type 2 diabetes is related to an increased risk of kidney stones; however, various forms of treatment for this condition may potentially reduce the risk of kidney stones. Kidney stone risk is lowered by a class of diabetes medications: Study Researchers at Mass General Brigham discovered that using sodium-glucose contratransporter 2 …
After the U.S. and Canada, India too has admitted incidence of a rare but serious infection of the genitals and area around the genitals among Type-2 diabetes patients using sodium-glucose cotransporter-2 inhibitors. Sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase IV inhibitors are recommended as preferred add-on oral anti-diabetic drugs after metformin among type-2 diabetes mellitus patients with atherosclerotic cardiovascular disease, heart …
